Published 10 days ago • loading... • Updated 10 days ago

Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Natera (NASDAQ:NTRA)

Adaptive Biotechnologies shares fall as Natera's Foresight acquisition heightens MRD competition and tempers recent takeover speculation.

Adaptive Biotechnologies shares fall as Natera's Foresight acquisition heightens MRD competition and tempers recent takeover speculation.

10 days ago·New York, United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated10 days agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States 10 days ago on Friday, December 5, 2025.

Sources are mostly out of (0)